Your browser doesn't support javascript.
loading
Mepolizumab improves quality of life and reduces activity impairments in patients with CRSwNP.
Bachert, C; Hellings, P W; Lund, V J; Fokkens, W J; Hopkins, C; Mayer, B; Chan, R H; Smith, S G; Sousa, A R; Alfonso-Cristancho, R; Yang, S; On Behalf Of The Synapse Study Group, On Behalf Of The Synapse Study Group.
Afiliación
  • Bachert C; Ghent University and Ghent University Hospital, Belgium; University of Stockholm, Stockholm, Sweden.
  • Hellings PW; Ghent University and Ghent University Hospital, Belgium; University of Leuven, Leuven, Belgium; Academic Medical Center, Amsterdam, the Netherlands.
  • Lund VJ; University College London, London, UK; Royal National Throat Nose and Ear Hospital, UCLH, London, UK.
  • Fokkens WJ; Academic Medical Center, Amsterdam, the Netherlands.
  • Hopkins C; Guys and St Thomas' Hospital, King's College, London, UK.
  • Mayer B; Clinical Statistics, GSK, GSK House, Brentford, Middlesex, UK.
  • Chan RH; Respiratory Patient-Centred Outcomes, Value Evidence and Outcomes, GSK, Brentford, Middlesex, UK.
  • Smith SG; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA.
  • Sousa AR; Respiratory Patient-Centred Outcomes, Value Evidence and Outcomes, GSK, Brentford, Middlesex, UK.
  • Alfonso-Cristancho R; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA.
  • Yang S; Value Evidence and Outcomes, GSK, Collegeville, PA, USA.
Rhinology ; 60(6): 474-478, 2022 Dec 01.
Article en En | MEDLINE | ID: mdl-36436220
ABSTRACT
Mepolizumab improves quality of life and reduces activity impairments in patients with CRSwNP.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Anticuerpos Monoclonales Humanizados Límite: Humans Idioma: En Revista: Rhinology Año: 2022 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Anticuerpos Monoclonales Humanizados Límite: Humans Idioma: En Revista: Rhinology Año: 2022 Tipo del documento: Article País de afiliación: Suecia